World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
39118
World Ranking
12952
National Ranking
495

Overview

Jan J. Cornelissen is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily focuses on Medicine with a significant emphasis on Hematology. Their work spans several interconnected subfields including Public Health, Environmental and Occupational Health, Genetics, Oncology, and Immunology.

Their scientific contributions cover a range of topics, including:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Jan J. Cornelissen has published extensively in several journals. The most frequent publication venues include:

  • Blood
  • Bone Marrow Transplantation
  • HemaSphere
  • Haematologica
  • Blood Advances

Among recent notable papers affiliated with or related to their research focus are:

  • Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19), 2021, Nature Communications
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2020, The Lancet Haematology
  • Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome, 2022, Blood
  • Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients, 2020, Bone Marrow Transplantation

Collaboration appears to be a prominent aspect of their research as evidenced by frequent co-authors, including:

  • Mohamad Mohty
  • Myriam Labopin
  • Arnon Nagler
  • Didier Blaise
  • Ibrahim Yakoub-Agha

Jan J. Cornelissen's work reflects a strong concentration on hematological malignancies and stem cell transplantation, integrating clinical and translational aspects. Their multidisciplinary approach spans molecular characterization, clinical management, and public health implications within the broader field of medicine.

Best Publications

  • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

    Stephen G. O'Brien;François Guilhot;Richard A. Larson;Insa Gathmann

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC + CD127 + natural killer–like cells

    Tom Cupedo;Natasha K Crellin;Natalie Papazian;Elwin J Rombouts

  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation

    Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis

  • Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).

    Jeroen J. A. van Kampen;David A. M. C. van de Vijver;Pieter L. A. Fraaij;Bart L. Haagmans

  • Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

    Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

  • Prevalence and Clinical Symptoms of Human Metapneumovirus Infection in Hospitalized Patients

    Bernadette G. van den Hoogen;Gerard J. J. van Doornum;John C. Fockens;Jan J. Cornelissen

  • Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

    Mahmoud al-Jurf;Mahmoud al-Jurf;Francisco Aranha;Francisco Aranha;Claudio Annasetti;Jane F. Apperley;Jane F. Apperley

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Acute myeloid leukaemia.

    Asim Khwaja;Magnus Bjorkholm;Rosemary E Gale;Ross L Levine

  • Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT

    Joost W. J. van Esser;Bronno van der Holt;Ellen Meijer;Hubert G. M. Niesters

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

    P. Ljungman;M. Bregni;M. Brune;J. Cornelissen

  • Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

    A. E. C. Broers;R. van der Holt;J. W. J. van Esser;J. W. Gratama

  • Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation.

    Joost W. J. van Esser;Hubert G. M. Niesters;Bronno van der Holt;Ellen Meijer

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections

    Acap Leenders;Simon Daenen;Rlh Jansen;Wcj Hop

  • Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

    Jan W. Gratama;Joost W. J. van Esser;Cor H. J. Lamers;Claire Tournay

  • Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Anna Sureda;Stephen Robinson;Carmen Canals;Angelo M. Carella

  • Development of a Real-Time Quantitative Assay for Detection of Epstein-Barr Virus

    H. G. M. Niesters;J. van Esser;E. Fries;K. C. Wolthers

  • Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

    Salut Brunet;Myriam Labopin;Jordi Esteve;Jan Cornelissen

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Myriam Labopin
Myriam Labopin Université Paris Cité
Gérard Socié
Gérard Socié Université Paris Cité
Bob Löwenberg
Bob Löwenberg Erasmus MC
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha University of Lille
Jakob Passweg
Jakob Passweg University Hospital of Basel
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Dietger Niederwieser
Dietger Niederwieser Leipzig University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of specialized healthcare careers beyond becoming a physician. Many students consider alternative or complementary pathways, such as healthcare administration, nursing leadership, pharmacy practice, and health information management.

For those interested in the business and organizational side of healthcare, pursuing one of the cheapest mha programs online is an excellent option. These programs prepare graduates for roles leading hospitals and healthcare systems.

Nurses looking to advance their clinical expertise may explore the best dnp programs online. Earning a Doctor of Nursing Practice (DNP) can open opportunities in advanced practice, administration, and teaching.

For those drawn to medication management and patient care, there are increasingly flexible online pharm d programs offering paths to become a licensed pharmacist.

Technology-driven roles are also growing. Earning a degree through rhia certification programs online can pave the way to becoming a Registered Health Information Administrator (RHIA), an essential role in medical data and compliance.

With a wide range of accredited and affordable online degrees, future healthcare professionals can find the right fit for their career goals and schedules.

Best Scientists Citing Jan J. Cornelissen

Trending Scientists